Drug Coverage
Drug Coverage
Navigating Drug Formularies
Schaeffer experts evaluate trends in drug formularies and utilization restrictions to determine whether patients are getting access to high-value medicines.
Related Topics
Top Drug Coverage Stories View All
Comment Letter
Comments on National Coverage Analysis: Transcatheter Aortic Valve Replacement and Broader CED Policy Considerations
Featured Experts: Darius Lakdawalla, Barry Liden
In The News View All
Los Angeles Times
USC Schaeffer scholars quoted on the rollout of TrumpRx
Featured Experts: Geoffrey Joyce, Darius Lakdawalla
Bloomberg
Lakdawalla argues for a drug pricing system aligned with American values
Featured Experts: Darius Lakdawalla
Medscape
Peters interviewed about how new GLP-1 guidelines and price reductions will affect patients
Featured Experts: Anne Peters
Modern Healthcare
Sood explains how newer, alternative PBMs often have business with legacy firms
Featured Experts: Neeraj Sood
KFF
Lakdawalla discusses recent developments in drug pricing policy on KFF webinar
Featured Experts: Darius Lakdawalla
Featured Perspective
A Missed Chance to Make America Healthier and Richer
Medicare should revisit its decision not to broadly cover anti-obesity medications, considering the enormous value expanded access would generate for society.
Experts: Alison Sexton Ward, Dana Goldman
Drug Coverage
Experts
Featured Research
Medicare Part D Plans Increased Restrictions on Drug Coverage
Medicare Part D plans excluded more compounds from coverage or subjected more of them to review before patients can access treatments, USC researchers found.
Experts: Geoffrey Joyce, Karen Van Nuys
